Gujarat Kidney And Super Speciality Limited Closes Trading Window from April 1, 2026
Gujarat Kidney And Super Speciality Limited will close its trading window from April 1, 2026. This is in compliance with SEBI's insider trading regulations. The window will reopen 48 hours after the declaration of audited financial results for the year ended March 31, 2026.
This is a routine regulatory requirement and does not indicate any new material information about the company's performance or future outlook.
The announcement is a routine regulatory disclosure regarding the closure of the trading window, which is a standard procedure. It does not contain any new financial information or business developments.
Gujarat Kidney And Super Speciality Limited has announced the closure of the trading window for dealing in the company's equity shares. This closure is in accordance with the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct.
The trading window will be closed for all Designated Persons, including Directors, Promoters, Promoter Group, persons acting in concert, their immediate relatives, and other connected persons. The closure period commences from Wednesday, April 1, 2026. It will remain closed until 48 hours after the declaration of the Audited Financial Results for the financial year ended March 31, 2026.
The date for the Board Meeting to declare these audited financial results will be communicated in due course.
What to do with a filing like this
Gujarat Kidney And Super Speciality Limited filed this with the NSE as a statutory disclosure, categorised under trading window disclosure. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Kidney And Super Speciality Limited. Read the original for the full detail.